Ignite Creation Date:
2025-12-24 @ 9:22 PM
Ignite Modification Date:
2026-02-17 @ 6:43 PM
Study NCT ID:
NCT03020004
Status:
COMPLETED
Last Update Posted:
2018-07-26
First Post:
2017-01-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Danoprevir/r + PR 12-week Triple Therapy in Treatment-Naive, Non-Cirrhotic, G1 CHC China II
Sponsor:
Ascletis Pharmaceuticals Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ASC08201502
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None